Pembrolizumab Therapy Triggering an Exacerbation of Preexisting Autoimmune Disease: A Report of 2 Patient Cases

Historically, metastatic melanoma was uniformly and rapidly lethal, and treatment options were limited. In recent years, however, checkpoint inhibitors have emerged as an accepted standard treatment for patients with advanced melanoma. In clinical trials, these agents have been largely well tolerate...

Descripción completa

Detalles Bibliográficos
Autores principales: Phadke, Sneha D., Ghabour, Ramez, Swick, Brian L., Swenson, Andrea, Milhem, Mohammed, Zakharia, Yousef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084516/
https://www.ncbi.nlm.nih.gov/pubmed/27826593
http://dx.doi.org/10.1177/2324709616674316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084516/
https://www.ncbi.nlm.nih.gov/pubmed/27826593
http://dx.doi.org/10.1177/2324709616674316

Ejemplares similares